Cargando…

The analysis of Fe-dependent serum enzymes in severe COVID-19 with a pulmonary thrombotic event

INTRODUCTION: COVID-19 patients in critical condition requiring ICU admission are more likely to experience thromboembolic complications, especially pulmonary embolism. Since the outbreak of coronavirus disease 2019 (COVID-19), clinicians have struggled with the attempt to diagnose and manage the se...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakiera, Jarosław, Grochowski, Cezary, Strzelec-Pawełczak, Karolina, Osuchowska-Grochowska, Ida, Szymański, Mateusz, Michalski, Aleksander, Kulczycka, Kinga, Czarnek, Katarzyna, Bogucki, Jacek, Blicharska, Eliza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901253/
https://www.ncbi.nlm.nih.gov/pubmed/36817400
http://dx.doi.org/10.5114/ceji.2022.124076
_version_ 1784882996552138752
author Bakiera, Jarosław
Grochowski, Cezary
Strzelec-Pawełczak, Karolina
Osuchowska-Grochowska, Ida
Szymański, Mateusz
Michalski, Aleksander
Kulczycka, Kinga
Czarnek, Katarzyna
Bogucki, Jacek
Blicharska, Eliza
author_facet Bakiera, Jarosław
Grochowski, Cezary
Strzelec-Pawełczak, Karolina
Osuchowska-Grochowska, Ida
Szymański, Mateusz
Michalski, Aleksander
Kulczycka, Kinga
Czarnek, Katarzyna
Bogucki, Jacek
Blicharska, Eliza
author_sort Bakiera, Jarosław
collection PubMed
description INTRODUCTION: COVID-19 patients in critical condition requiring ICU admission are more likely to experience thromboembolic complications, especially pulmonary embolism. Since the outbreak of coronavirus disease 2019 (COVID-19), clinicians have struggled with the attempt to diagnose and manage the severe and fatal complications of COVID-19 appropriately. Several reports have described significant procoagulatory events, including life-threatening pulmonary embolism, in these patients. The aim of the study was to analyze the results of selected serum enzymes in patients with a radiologically confirmed pulmonary thrombotic event based on the pulmonary tissue involvement assessed in a computed tomography (CT) scan. MATERIAL AND METHODS: The retrospective study covered a group of 226 COVID-19 patients. Groups were divided based on the degree of lung tissue involvement in CT examinations, including patients with confirmed pulmonary embolism. The analyzed group consisted of 136 men and 90 women with mean age of 70 years. RESULTS: The group consisted of patients with < 50% of lung volume changes who had higher parameter values in each analyzed parameter, except red blood cells (RBC) (p < 0.05). Especially, the level of ferritin was much higher in the first group (p = 0.000008). Elevated ferritin levels were observed in all patients with lung tissue involvement. DISCUSSION: This line of research is critical in order to assess the predisposing conditions for pulmonary embolism occurrence in COVID-19, which can be used as a predictive factor for course of the disease. The conducted research will resolve whether there is a relationship between the selected laboratory parameters and the occurrence of pulmonary embolism in patients with COVID-19. CONCLUSIONS: The study demonstrated that elevated levels of several inflammatory and thrombotic parameters such as ferritin, D-dimer, C-reactive protein (CRP) as well as hemoglobin do not correlate with the degree of lung tissue involvement in the computed tomography image.
format Online
Article
Text
id pubmed-9901253
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-99012532023-02-16 The analysis of Fe-dependent serum enzymes in severe COVID-19 with a pulmonary thrombotic event Bakiera, Jarosław Grochowski, Cezary Strzelec-Pawełczak, Karolina Osuchowska-Grochowska, Ida Szymański, Mateusz Michalski, Aleksander Kulczycka, Kinga Czarnek, Katarzyna Bogucki, Jacek Blicharska, Eliza Cent Eur J Immunol Clinical Immunology INTRODUCTION: COVID-19 patients in critical condition requiring ICU admission are more likely to experience thromboembolic complications, especially pulmonary embolism. Since the outbreak of coronavirus disease 2019 (COVID-19), clinicians have struggled with the attempt to diagnose and manage the severe and fatal complications of COVID-19 appropriately. Several reports have described significant procoagulatory events, including life-threatening pulmonary embolism, in these patients. The aim of the study was to analyze the results of selected serum enzymes in patients with a radiologically confirmed pulmonary thrombotic event based on the pulmonary tissue involvement assessed in a computed tomography (CT) scan. MATERIAL AND METHODS: The retrospective study covered a group of 226 COVID-19 patients. Groups were divided based on the degree of lung tissue involvement in CT examinations, including patients with confirmed pulmonary embolism. The analyzed group consisted of 136 men and 90 women with mean age of 70 years. RESULTS: The group consisted of patients with < 50% of lung volume changes who had higher parameter values in each analyzed parameter, except red blood cells (RBC) (p < 0.05). Especially, the level of ferritin was much higher in the first group (p = 0.000008). Elevated ferritin levels were observed in all patients with lung tissue involvement. DISCUSSION: This line of research is critical in order to assess the predisposing conditions for pulmonary embolism occurrence in COVID-19, which can be used as a predictive factor for course of the disease. The conducted research will resolve whether there is a relationship between the selected laboratory parameters and the occurrence of pulmonary embolism in patients with COVID-19. CONCLUSIONS: The study demonstrated that elevated levels of several inflammatory and thrombotic parameters such as ferritin, D-dimer, C-reactive protein (CRP) as well as hemoglobin do not correlate with the degree of lung tissue involvement in the computed tomography image. Termedia Publishing House 2023-01-13 2022 /pmc/articles/PMC9901253/ /pubmed/36817400 http://dx.doi.org/10.5114/ceji.2022.124076 Text en Copyright © 2022 Termedia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) )
spellingShingle Clinical Immunology
Bakiera, Jarosław
Grochowski, Cezary
Strzelec-Pawełczak, Karolina
Osuchowska-Grochowska, Ida
Szymański, Mateusz
Michalski, Aleksander
Kulczycka, Kinga
Czarnek, Katarzyna
Bogucki, Jacek
Blicharska, Eliza
The analysis of Fe-dependent serum enzymes in severe COVID-19 with a pulmonary thrombotic event
title The analysis of Fe-dependent serum enzymes in severe COVID-19 with a pulmonary thrombotic event
title_full The analysis of Fe-dependent serum enzymes in severe COVID-19 with a pulmonary thrombotic event
title_fullStr The analysis of Fe-dependent serum enzymes in severe COVID-19 with a pulmonary thrombotic event
title_full_unstemmed The analysis of Fe-dependent serum enzymes in severe COVID-19 with a pulmonary thrombotic event
title_short The analysis of Fe-dependent serum enzymes in severe COVID-19 with a pulmonary thrombotic event
title_sort analysis of fe-dependent serum enzymes in severe covid-19 with a pulmonary thrombotic event
topic Clinical Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901253/
https://www.ncbi.nlm.nih.gov/pubmed/36817400
http://dx.doi.org/10.5114/ceji.2022.124076
work_keys_str_mv AT bakierajarosław theanalysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent
AT grochowskicezary theanalysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent
AT strzelecpawełczakkarolina theanalysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent
AT osuchowskagrochowskaida theanalysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent
AT szymanskimateusz theanalysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent
AT michalskialeksander theanalysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent
AT kulczyckakinga theanalysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent
AT czarnekkatarzyna theanalysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent
AT boguckijacek theanalysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent
AT blicharskaeliza theanalysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent
AT bakierajarosław analysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent
AT grochowskicezary analysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent
AT strzelecpawełczakkarolina analysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent
AT osuchowskagrochowskaida analysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent
AT szymanskimateusz analysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent
AT michalskialeksander analysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent
AT kulczyckakinga analysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent
AT czarnekkatarzyna analysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent
AT boguckijacek analysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent
AT blicharskaeliza analysisoffedependentserumenzymesinseverecovid19withapulmonarythromboticevent